| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e506edf9057604b5c2c697bcff416bf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37da2b61255929079a1ef54b9bf45562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad7b881512fd6c1d8bb335afadf5c3b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c02242c6f7f5e4b279dfd34da70b08fb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ada7406b4d456a78354fad6dd6f92af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c872490effb9fbf4390fc65188e7995a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f432de11bc727b837330bd802734a825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7eb4081de801e22e7567a118548cf2a |
| publicationDate |
2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007286874-A1 |
| titleOfInvention |
Recombinant attenuated clostridium organisms and vaccine |
| abstract |
The present invention discloses attenuated Clostridium perfringens organisms that express a substantially nontoxic alpha-toxin. The expressed alpha-toxin is a deletion mutein that relative to the alpha-toxin of the mature alpha-toxin of Clostridium perfringens strain 13, is missing at least nine consecutive amino acid residues including His 68 . The present invention also discloses attenuated organisms that encode the muteins, as well as the use of such attenuated organisms as vaccines. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406702-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973908-B1 |
| priorityDate |
2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |